CRNX vs MNST · rev $35.9M vs P/E 46, rev $4.89B
Crinetics Pharmaceuticals Inc (CRNX) versus Monster Beverage Corp (MNST) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Monster Beverage Corp (MNST) is a beverages - non-alcoholic company listed on US.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
Latest reported MNST revenue for 2026-06-30 was $4.89B. Net income was $1.15B. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
CRNX currently screens at market cap $2.76B. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
Not investment advice. Open the CRNX and MNST stock pages for the full models.
Not investment advice.